1. Home
  2. NSPR vs COHN Comparison

NSPR vs COHN Comparison

Compare NSPR & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

N/A

Current Price

$13.95

Market Cap

32.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
COHN
Founded
2005
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
32.9M
IPO Year
2009
2003

Fundamental Metrics

Financial Performance
Metric
NSPR
COHN
Price
$0.72
$13.95
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
85.7K
15.6K
Earning Date
05-04-2026
05-01-2026
Dividend Yield
N/A
4.35%
EPS Growth
N/A
5537.50
EPS
N/A
0.42
Revenue
$2,310,000.00
$275,564,000.00
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
$33.31
Revenue Growth
N/A
246.19
52 Week Low
$0.63
$9.19
52 Week High
$2.93
$32.60

Technical Indicators

Market Signals
Indicator
NSPR
COHN
Relative Strength Index (RSI) 39.07 57.48
Support Level $0.69 $12.84
Resistance Level $1.04 $14.50
Average True Range (ATR) 0.03 0.60
MACD 0.01 0.13
Stochastic Oscillator 71.29 67.39

Price Performance

Historical Comparison
NSPR
COHN

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

Share on Social Networks: